vimarsana.com
Home
Live Updates
Sobi to present new data at the ASH 2021 Annual Meeting : vimarsana.com
Sobi to present new data at the ASH 2021 Annual Meeting
/PRNewswire/ -- Sobi™ will present new data at the 63rd Annual Meeting of the American Society of Hematology (ASH) taking place from 11-14 December 2021....
Related Keywords
Norway
,
Georgia
,
United States
,
Australia
,
Japan
,
United Kingdom
,
Brazil
,
Liechtenstein
,
Canada
,
Russia
,
Iceland
,
New Zealand
,
Stockholm
,
Sweden
,
Kuwait
,
Saudi Arabia
,
Georgia World Congress Center
,
Switzerland
,
America
,
American
,
Hemophagocytic Lymphohistiocytosis
,
Ravi Rao
,
Elocta Eloctate
,
Prnewswire Sobi
,
European Commission
,
Sobi Investor Relations Team
,
Clinical Development Program
,
Meeting Of The American Society Hematology
,
Group Trial
,
Us Food Drug Administration
,
European Medicines Agency
,
Committee For Medicinal Products Human Use
,
Head Of Research Development
,
Annual Meeting
,
American Society
,
Chief Medical Officer
,
Delays Time
,
First Spontaneous Bleed Event
,
Previously Untreated Patients
,
Post Hoc Analysis
,
Session Time
,
Presentation Time
,
Alfa Half Life
,
Clearance Are Independent
,
Willebrand Factor
,
Severe Hemophilia
,
Observational Descriptive Study
,
Antihemophilic Factor
,
Pegcetacoplan Treatment
,
Paroxysmal Nocturnal Hemoglobinuria
,
Georgia Ballroom
,
Hemoglobin Measures Observed
,
Real World Evidence
,
Hoc Analysis
,
Baseline Hemoglobin Levels Greater Than
,
Long Term Safety
,
Paroxysmal Nocturnal Hemoglobinuria Patients
,
Hematologic Response
,
Platelet Response When Switching
,
Immune Thrombocytopenia
,
Thromboembolic Events
,
Platelet Count Occurring
,
Avatrombopag Immune Thrombocytopenia
,
Clinical Development
,
Observational Multicenter Study
,
Adult Patients
,
Double Blind Placebo Controlled
,
Parallel Group Trial
,
Open Label Extension Phase
,
Pediatric Patients
,
Primary Hemophagocytic Lymphohistiocytosis
,
World Treatment Patterns
,
Activation Syndrome
,
Systemic Juvenile Idiopathic Arthritis
,
Anti Interferon Gamma
,
Single Arm Study
,
Monoclonal Antibody
,
Macrophage Activation Syndrome
,
Drug Administration
,
Medicinal Products
,
Human Use
,
Orphan Drug Designation
,
North America
,
Middle East
,
Sobi Media
,
Cision Ab
,
vimarsana.com © 2020. All Rights Reserved.